obinutuzumab
pharmaceutical drug
Press Enter · cited answer in seconds
0 sources
obinutuzumab
Summary
obinutuzumab is a type of chemical entity[1]. obinutuzumab has Wikipedia articles in 11 language editions, a strong signal of global cultural recognition.[2]
Key Facts
- obinutuzumab's instance of is recorded as type of chemical entity[3].
- obinutuzumab's chemical formula is recorded as C₆₅₁₂H₁₀₀₆₀N₁₇₁₂O₂₀₂₀S₄₄[4].
- obinutuzumab is a type of chemical compound[5].
- obinutuzumab is used for medication[6].
- obinutuzumab's has characteristic is recorded as biopharmaceutical[7].
- obinutuzumab's medical condition treated is recorded as mantle cell lymphoma[8].
- obinutuzumab's medical condition treated is recorded as B-cell lymphoma[9].
- obinutuzumab's medical condition treated is recorded as non-Hodgkin lymphoma[10].
- obinutuzumab's medical condition treated is recorded as diffuse large B-cell lymphoma[11].
- obinutuzumab's medical condition treated is recorded as chronic lymphocytic leukemia[12].
- obinutuzumab's subject has role is recorded as immunological antineoplastic agent[13].
- obinutuzumab's subject has role is recorded as monoclonal antibody[14].
- obinutuzumab's legal status is recorded as boxed warning[15].
- obinutuzumab's active ingredient in is recorded as Gazyvaro[16].
Why It Matters
obinutuzumab has Wikipedia articles in 11 language editions, a strong signal of global cultural recognition.[2] obinutuzumab is known by 14 alternative names across languages and contexts.[17]